Amprologix engages corporate finance partners FRP for its…
2 December 2020We are delighted to be working with Adrian Gare and Alex Starling at FRP, who have a great track record…
Amprologix CSO collaborates with Dr Max Ryadnov from the UK’s National Physical Laboratory, to publish new data on the novel mode of action of epidermicin NI01. Findings are reported in the August issue of iScience.